F-Prime Capital

Founded 1946

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 278
Average round size
info
The average size of a deal this fund participated in
$35M
Portfolio companies 183
Rounds per year 3.71
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Exits 60
Key employees 11
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Software

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Oviva

Consulting
Health Care
Personal Health
1
$94M31 Aug 2021 United Kingdom, London

Moneyworld

FinTech
1
$2M17 Aug 2021 United States, New York

Innovusion

Automotive
Sensor
1
$66M13 Aug 2021 United States, Sunnyvale

MoEngage

Analytics
Digital Marketing
Information Technology
Internet
Marketing Automation
Mobile
SaaS
1
$32M30 Jul 2021 United States, San Francisco

SonderMind

Health Care
Marketplace
mHealth
Software
Therapeutics
Wellness
1
$150M28 Jul 2021 United States, Denver

Embark

Animal Feed
Biotechnology
Genetics
Health Care
Pet
Veterinary
1
$75M26 Jul 2021 United States, Boston

Turnstone Biologics

Biotechnology
Innovation Management
Therapeutics
1
$80M14 Jul 2021 United States, San Francisco

Prime Medicine

Biotechnology
Medical
1
$200M13 Jul 2021 United States, Cambridge

Orient Speech Therapy Center

Education
Language Learning
Speech Recognition
1
$60M25 Jun 2021 China, " China"}
News
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.

Centivo raises $51 million as more employers seek affordable, quality healthcare for their employees

– Centivo, a new health plan for self-funded employers that is anchored around leading providers of value-based care, announced today that it has raised an additional $51 million in funding.
B Capital Group, a leading global technology investor, and Maverick co-led the round.
– Additional existing investors, including Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures, an AVG fund and various individuals also participated.
– These funds will support Centivo’s rapid growth and expansion amid increased demand from employers for health plans that are structurally built to address employee healthcare affordability.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent F-Prime Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: